The Director General of Pharmaceutical Products at the Food and Drug Organization stated: In wartime conditions and simultaneously with supply constraints and economic pressures, utilizing domestic production capacity and replacing expensive imported drugs with high-quality Iranian alternatives has been prioritized to ensure patients have access to essential medications.
Over 60% of the country's pharmaceutical market is supplied by domestic producers
The Iranian government is prioritizing domestic pharmaceutical production to ensure access to essential medications amid wartime conditions and economic pressures. This initiative aims to replace costly imported drugs with quality local alternatives. It highlights the country's efforts to bolster self-sufficiency in healthcare.
👥 Key Players
📰 What Happened
The Iranian government has announced that over 60% of the pharmaceutical market is now supplied by domestic producers. This shift aims to ensure access to essential medications during wartime and economic challenges by prioritizing local production over expensive imports.
- Domestic production now accounts for over 60% of the pharmaceutical market in Iran.
- The initiative is a response to wartime conditions and economic pressures.
💡 Why It Matters
📚 Background
Iran has faced significant economic pressures due to sanctions and ongoing conflicts, leading to a focus on self-sufficiency in various sectors, including healthcare.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%